Category Archives: Coronary Heart Diseases

Database and study population The data in this study were all obtained from a large publicly accessible MIMIC-IV database version 2.2 (https://mimic.physionet.org/about/mimic/), which is the latest version that encompasses extensive clinical data from patients admitted to the Beth Israel Deaconess Medical Center between 2008 and 2019. MIMIC-IV contains more than 50,000 admissions information for adult patients including demographic characteristics, laboratory tests results, medication treatment, vital signs and other comprehensive information39. To obtain access, one author (ZLZ) completed web-based training courses and exams and gained full access to the database (certification number: 53158939) Continue reading →

Lenfant C. Chest pain of cardiac and noncardiac origin Continue reading →

Recent research conducted by the German Center for Diabetes Research and associated institutions has identified novel protein biomarkers that predict the risk of developing coronary heart disease in individuals with and without type 2 diabetes. This breakthrough offers new insights into the diseases mechanisms and potential avenues for prevention and treatment. Coronary heart disease (CHD) stands as a significant health challenge worldwide, particularly for individuals with type 2 diabetes Continue reading →

Visseren FLJ, Mach F, Smulders YM, Carballo D, Koskinas KC, et al. 2021 ESC guidelines on cardiovascular disease prevention in clinical practice. Continue reading →

Naghavi, M. et al. Continue reading →

November 17, 2023 Researchers from the University of Minnesota Medical School examining the cause of cardiomyopathy discovered one out of every six patients with coronary artery disease had non-ischemic or dual cardiomyopathy. The findings of this study werepublished this week in the peer-reviewed journalCirculation,the flagship journal of the American Heart Association Continue reading →

Hemler EC, Hu FB. Plant-based diets for personal, population, and planetary health Continue reading →

The presence of positive antiphospholipid antibodies (aPLs) is associated with future atherosclerotic cardiovascular disease (ASCVD) risk among individuals with systemic lupus erythematosus (SLE).1 These findings were presented at the American College of Rheumatology (ACR) 2023 Convergence held in San Diego, California. The studys investigators pointed to the fact that those with diagnoses of SLE are known to have a rising susceptibility to cardiovascular diseases, adding that the incidence is 23.3 events per 1000 patient-years. The investigators presenting this data noted that aPLs are autoantibodies that are known to impact phospholipid-binding proteins Continue reading →

Park LT, Zarate CA. Jr. Continue reading →

Covid-19 hasnt gone away. But, almost four years after it was first identified, the infectious disease certainly features less in the zeitgeist. Continue reading →